Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Keratosis, Actinic × Melatonin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Neoplasms 5 Parasomnias 4 Depression 3 Tuberous Sclerosis 2 Smith-Magenis Syndrome 2 Sleep Wake Disorders 2 Polycystic Ovary Syndrome 2 Pain 2 Fatigue 2 Autism Spectrum Disorder 2 Anxiety Disorders 2 Angelman Syndrome 2 Weight Loss 1 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Disorders, Circadian Rhythm 1 Relapsed Malignant Solid Tumor 1 Radiodermatitis 1 Radiation Injuries 1 Quality of Life 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Keratosis, Actinic 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Female Breast Cancer 1 Delirium 1

Interventions

3-ingenyl angelate 37 Aminolevulinic Acid 29 Imiquimod 24 Fluorouracil 22 Photochemotherapy 21 Gels 12 Cryotherapy 12 Diclofenac 11 methyl 5-aminolevulinate 10 tirbanibulin 6 calcipotriene 5 Solutions 5 Petrolatum 5 Ointments 5 LEO 43204 5 Radiotherapy 4 Prilocaine 4 Lidocaine 4 BF-200 ALA 4 Therapeutics 3 Niacinamide 3 Cryosurgery 3 1-phenyl-3,3-dimethyltriazene 3 SR-T100 2 Phototherapy 2 Imipramine 2 Deoxyribonuclease (Pyrimidine Dimer) 2 Celecoxib 2 tazarotene 1 potassium dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05740969 2023-02-23

PACKS

Zealand University Hospital

Phase 2 Unknown

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡